Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting histone demethylases KDM5A and KDM5B in AML cancer cells: A comparative view
Gelareh Shokri, Shaghayegh Doudi, Mehrnoosh Fathi‐Roudsari, et al.
Leukemia Research (2018) Vol. 68, pp. 105-111
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies
Ailin Zhao, Hui Zhou, Jinrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 64
The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways
Nourhan M. Abdelmaksoud, Hesham A. El-Mahdy, Ahmed Ismail, et al.
Pathology - Research and Practice (2023) Vol. 244, pp. 154411-154411
Closed Access | Times Cited: 56
Epigenetic Targeting of Glioblastoma
Massimo Romani, Maria Pia Pistillo, Barbara Banelli
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 102
JMJD family proteins in cancer and inflammation
Manni Wang, Jianxin Xue, Weiqi Hong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 54
Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapy
Moon Nyeo Park, Jinwon Choi, Md. Maharub Hossain Fahim, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
(R)-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation inIDH-Mutant Cancers
Kathryn Gunn, Matti Myllykoski, John Z. Cao, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1478-1497
Open Access | Times Cited: 23
The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response
Eva De Smedt, Hui Lui, Ken Maes, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 47
Epigenetic Targets and their Inhibitors in Cancer Therapy
Le Zhao, Yongtao Duan, Ping Lü, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 18, Iss. 28, pp. 2395-2419
Closed Access | Times Cited: 45
Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors
Yi Zhang, Deqin Rong, Bingbing Li, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 7900-7925
Closed Access | Times Cited: 38
Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target
Yi‐Chao Zheng, Jiao Chang, Lin-Chen Wang, et al.
European Journal of Medicinal Chemistry (2018) Vol. 161, pp. 131-140
Closed Access | Times Cited: 46
Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis
Jiaojuan Huang, Shuiling Jin, Rongqun Guo, et al.
RNA (2024) Vol. 30, Iss. 4, pp. 435-447
Closed Access | Times Cited: 4
Targeting histone demethylase KDM5B for cancer treatment
Yun-Dong Fu, Ming-Jie Huang, Jia–Wen Guo, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112760-112760
Closed Access | Times Cited: 30
The KDM5A/HOXA5 axis regulates osteosarcoma progression via activating the Wnt/β-catenin pathway
Yi Luo, Youzhi He, Yuxia Xu, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A
J.R. Horton, Clayton B. Woodcock, Qin Chen, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 23, pp. 10588-10601
Open Access | Times Cited: 32
Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma
Lijie Li, Huafeng Shou, Qianqian Wang, et al.
Gene (2019) Vol. 694, pp. 76-82
Closed Access | Times Cited: 28
Emerging epigenetic therapeutics for myeloid leukemia: modulating demethylase activity with ascorbate
Andrew B. Das, Carlos C. Smith-Díaz, Margreet C.M. Vissers
Haematologica (2020)
Open Access | Times Cited: 23
KDM5A suppresses PML-RARα target gene expression and APL differentiation through repressing H3K4me2
Siyuan Xu, Siqing Wang, Shenghui Xing, et al.
Blood Advances (2021) Vol. 5, Iss. 17, pp. 3241-3253
Open Access | Times Cited: 19
Histone Methylation Related Therapeutic Challenge in Cardiovascular Diseases
Yang Yang, Ying Luan, Ruixia Yuan, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 19
KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance
Solenne Gaillard, Virginie Charasson, Cyril Ribeyre, et al.
Biology Open (2021) Vol. 10, Iss. 5
Open Access | Times Cited: 18
Characterization of bone marrow heterogeneity in NK-AML (M4/M5) based on single-cell RNA sequencing
Wenqi Wu, Zeyan Shi, Zhongyuan Tang, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells
Jacopo Albanesi, Nélida I. Noguera, Cristina Banella, et al.
Cells (2020) Vol. 9, Iss. 11, pp. 2423-2423
Open Access | Times Cited: 17
Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort
Somayye Taghvaei, Farzaneh Sabouni, Zarrin Minuchehr
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 15
Gene mutation analysis using next‐generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi‐center study from China
Junnan Li, Pei Li, Simin Liang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 8, pp. 9332-9350
Open Access | Times Cited: 6
RETRACTED: KDM5B-mediated microRNA-448 up-regulation restrains papillary thyroid cancer cell progression and slows down tumor growth via TGIF1 repression
Ying Pu, Juan Xiang, Jiani Zhang
Life Sciences (2020) Vol. 250, pp. 117519-117519
Closed Access | Times Cited: 13
Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis
Swati S. Bhasin, Beena Thomas, Ryan J. Summers, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top